Cadence Pharmaceuticals Inc (CADX)

Currency in USD
13.980
0.000(0.00%)
Closed·
Showing Cadence historical data. For real-time data please try another search
Day's Range
13.96014.020
52 wk Range
0.00014.020
Key Statistics
Prev. Close
13.98
Open
13.995
Day's Range
13.96-14.02
52 wk Range
0-0
Volume
-
Average Volume (3m)
342.7K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Cadence Pharmaceuticals Inc Company Profile

Cadence Pharmaceuticals, Inc., a biopharmaceutical company, focuses on acquiring, in-licensing, developing, and commercializing proprietary products principally for use in the hospital setting. The company holds the rights to OFIRMEV injection, a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, and the reduction of fever in adults and children. It distributes its products primarily through drug wholesalers to anesthesiologists and surgeons, as well as nurse anesthetists, emergency medicine physicians, intensivists, internists, hospitalists, obstetricians, and other physicians. Cadence Pharmaceuticals, Inc. was founded in 2004 and is headquartered in San Diego, California. As of March 18, 2014, Cadence Pharmaceuticals Inc. operates as a subsidiary of Mallinckrodt plc.

Employees
210

Earnings

Latest Release
Mar 04, 2019
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CADX Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.